About the Authors
- Oliver Medvedik
-
Contributed equally to this work with: Oliver Medvedik, Dudley W Lamming
Affiliation Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
- Dudley W Lamming
-
Contributed equally to this work with: Oliver Medvedik, Dudley W Lamming
Affiliation Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
- Keyman D Kim
-
Affiliation Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
- David A Sinclair
-
*To whom correspondence should be addressed. E-mail: david_sinclair@hms.harvard.edu
Affiliation Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
DAS is a founder, director, share holder, and scientific consultant to Sirtris Pharmaceuticals, a company whose goal is to develop sirtuin-activating molecules to treat disease.
Author Contributions
OM, DWL, and DAS conceived and designed the experiments. OM, DWL, and KDK performed the experiments. All authors analyzed the data. OM, DWL, and DAS contributed reagents/materials/analysis tools and wrote the paper.